Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hong

Showing results (191-200 of 273) with videos related to

Pageof 28
Sort By:
Molecular Cancer Therapeutics|July 29, 2016
TP53 Alterations Correlate with Response to VEGF/VEGFR Inhibitors: Implications for Targeted TherapeuticsJennifer J Wheler, Filip Janku, Aung Naing, et al.
The Oncologist|August 25, 2018
Comparative Effectiveness of an mTOR-Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple-Negative Breast CancerReva K Basho, Clinton Yam, Michael Gilcrease, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 30, 2021
Microbial Cell-Free DNA Identifies Etiology of Bloodstream Infections, Persists Longer Than Conventional Blood Cultures, and Its Duration of Detection Is Associated With Metastatic Infection in Patients With Staphylococcus aureus and Gram-Negative BacteremiaEmily M Eichenberger, Christiaan R de Vries, Felicia Ruffin, et al.
Frontiers in Cardiovascular Medicine|September 1, 2022
Prognostic implications of coronary artery disease and stress tests in patients with elevated left ventricular filling pressure and preserved ejection fractionJeong Hun Seo, David Hong, Taeho Youn, et al.
European Journal of Medicinal Chemistry|January 3, 2025
Novel antimalarial 3-substituted quinolones isosteres with improved pharmacokinetic propertiesSiyuan Ge, Rongchao Jian, Qiwei Xuan, et al.
Clinical Pharmacology in Drug Development|June 26, 2024
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Trial of AWZ1066S, an Anti-Wolbachia Candidate MacrofilaricideGraham Devereux, Marcin Bula, Karen Tripp, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2022
Microbial Cell-Free DNA Identifies the Causative Pathogen in Infective Endocarditis and Remains Detectable Longer Than Conventional Blood Culture in Patients with Prior Antibiotic TherapyEmily M Eichenberger, Nicholas Degner, Erick R Scott, et al.
Implementation Science : IS|January 8, 2021
Protocol for a hybrid type 2 cluster randomized trial of trauma-focused cognitive behavioral therapy and a pragmatic individual-level implementation strategyAaron R Lyon, Michael D Pullmann, Shannon Dorsey, et al.
Journal of Hematology & Oncology|July 3, 2026
KRAS inhibition is an effective therapy for appendiceal adenocarcinomaSaikat Chowdhury, Ichiaki Ito, Vinay K Pattalachinti, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|December 5, 2022
Prognostic Impact of Indeterminate Diastolic Function in Patients With Functionally Insignificant Coronary StenosisYu Jin Chung, Ki Hong Choi, Seung Hun Lee, et al.
Pageof 28

Showing results (191-200 of 273) with videos related to

Sort By:
Pageof 28
Molecular Cancer Therapeutics|July 29, 2016
TP53 Alterations Correlate with Response to VEGF/VEGFR Inhibitors: Implications for Targeted TherapeuticsJennifer J Wheler, Filip Janku, Aung Naing, et al.
The Oncologist|August 25, 2018
Comparative Effectiveness of an mTOR-Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple-Negative Breast CancerReva K Basho, Clinton Yam, Michael Gilcrease, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 30, 2021
Microbial Cell-Free DNA Identifies Etiology of Bloodstream Infections, Persists Longer Than Conventional Blood Cultures, and Its Duration of Detection Is Associated With Metastatic Infection in Patients With Staphylococcus aureus and Gram-Negative BacteremiaEmily M Eichenberger, Christiaan R de Vries, Felicia Ruffin, et al.
Frontiers in Cardiovascular Medicine|September 1, 2022
Prognostic implications of coronary artery disease and stress tests in patients with elevated left ventricular filling pressure and preserved ejection fractionJeong Hun Seo, David Hong, Taeho Youn, et al.
European Journal of Medicinal Chemistry|January 3, 2025
Novel antimalarial 3-substituted quinolones isosteres with improved pharmacokinetic propertiesSiyuan Ge, Rongchao Jian, Qiwei Xuan, et al.
Clinical Pharmacology in Drug Development|June 26, 2024
A Phase 1, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Trial of AWZ1066S, an Anti-Wolbachia Candidate MacrofilaricideGraham Devereux, Marcin Bula, Karen Tripp, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2022
Microbial Cell-Free DNA Identifies the Causative Pathogen in Infective Endocarditis and Remains Detectable Longer Than Conventional Blood Culture in Patients with Prior Antibiotic TherapyEmily M Eichenberger, Nicholas Degner, Erick R Scott, et al.
Implementation Science : IS|January 8, 2021
Protocol for a hybrid type 2 cluster randomized trial of trauma-focused cognitive behavioral therapy and a pragmatic individual-level implementation strategyAaron R Lyon, Michael D Pullmann, Shannon Dorsey, et al.
Journal of Hematology & Oncology|July 3, 2026
KRAS inhibition is an effective therapy for appendiceal adenocarcinomaSaikat Chowdhury, Ichiaki Ito, Vinay K Pattalachinti, et al.
Journal of the American Society of Echocardiography : Official Publication of the American Society of Echocardiography|December 5, 2022
Prognostic Impact of Indeterminate Diastolic Function in Patients With Functionally Insignificant Coronary StenosisYu Jin Chung, Ki Hong Choi, Seung Hun Lee, et al.
Pageof 28